- Home
- AIRI vs IBO Comparison
AIRI vs IBO Comparison
Compare AIRI & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- IBO
- Stock Information
- Founded
- AIRI 1979
- IBO 2018
- Country
- AIRI United States
- IBO United States
- Employees
- AIRI N/A
- IBO N/A
- Industry
- AIRI Military/Government/Technical
- IBO
- Sector
- AIRI Industrials
- IBO
- Exchange
- AIRI Nasdaq
- IBO NYSE
- Market Cap
- AIRI 15.4M
- IBO 16.5M
- IPO Year
- AIRI N/A
- IBO 2024
- Fundamental
- Price
- AIRI $4.35
- IBO $1.57
- Analyst Decision
- AIRI
- IBO
- Analyst Count
- AIRI 0
- IBO 0
- Target Price
- AIRI N/A
- IBO N/A
- AVG Volume (30 Days)
- AIRI 45.8K
- IBO 32.6K
- Earning Date
- AIRI 11-14-2024
- IBO 11-12-2024
- Dividend Yield
- AIRI N/A
- IBO N/A
- EPS Growth
- AIRI N/A
- IBO N/A
- EPS
- AIRI N/A
- IBO 0.01
- Revenue
- AIRI $53,657,000.00
- IBO N/A
- Revenue This Year
- AIRI $9.26
- IBO N/A
- Revenue Next Year
- AIRI $8.73
- IBO N/A
- P/E Ratio
- AIRI N/A
- IBO $187.06
- Revenue Growth
- AIRI 3.31
- IBO N/A
- 52 Week Low
- AIRI $3.00
- IBO $1.22
- 52 Week High
- AIRI $9.44
- IBO $3.25
- Technical
- Relative Strength Index (RSI)
- AIRI 38.83
- IBO N/A
- Support Level
- AIRI $4.11
- IBO N/A
- Resistance Level
- AIRI $4.60
- IBO N/A
- Average True Range (ATR)
- AIRI 0.26
- IBO 0.00
- MACD
- AIRI 0.02
- IBO 0.00
- Stochastic Oscillator
- AIRI 30.77
- IBO 0.00
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.